Cyclopamine is a novel Hedgehog signaling inhibitor with significant anti-proliferative, anti-invasive and anti-estrogenic potency in human breast cancer cells.
about
Tamoxifen Resistance: Emerging Molecular TargetsThe Potential Role of Hedgehog Signaling in the Luminal/Basal Phenotype of Breast Epithelia and in Breast Cancer Invasion and MetastasisOestrogen receptor-alpha regulates non-canonical Hedgehog-signalling in the mammary gland.Chemoradiation therapy using cyclopamine-loaded liquid-lipid nanoparticles and lutetium-177-labeled core-crosslinked polymeric micelles.Combination of cyclopamine and tamoxifen promotes survival and migration of mcf-7 breast cancer cells--interaction of hedgehog-gli and estrogen receptor signaling pathways.Targeting of sonic hedgehog-Gli signaling: A potential therapeutic target for patients with breast cancerRhoA-Rho kinase and platelet-activating factor stimulation of ovine foetal pulmonary vascular smooth muscle cell proliferation.Cyclopamine-loaded core-cross-linked polymeric micelles enhance radiation response in pancreatic cancer and pancreatic stellate cells.Antiproliferative and Antiestrogenic Activities of Bonediol an Alkyl Catechol from Bonellia macrocarpaGli3 silencing enhances cyclopamine suppressive effects on ovarian cancer.Casticin inhibits the epithelial-mesenchymal transition in ovarian carcinoma via the hedgehog signaling pathway.Glioma-Associated Oncogene Homolog Inhibitors Have the Potential of Suppressing Cancer Stem Cells of Breast Cancer.The "Yin and Yang" of Natural Compounds in Anticancer Therapy of Triple-Negative Breast Cancers
P2860
Q26739969-E319A169-56B2-4FCB-99E0-50179BC79886Q26782727-8B718547-57FA-4E5C-A2BE-579031F360BFQ34038494-A189CC7F-7B35-4005-A557-47325C54C0D9Q35388439-8AE209C8-21B7-4E6E-AF85-E718136A1BADQ35517805-89CA367F-3881-4CF9-8DCC-BB607F77B887Q37108287-02588613-EEA9-4293-B67A-FE0ACE4EEB6DQ37209956-86E1495B-C590-4E35-A462-58E2AE47033DQ37322264-6892A842-2456-4E30-96B3-0EAF6E86A449Q41762241-8717E30B-B375-45D9-A315-E9EA40BD690CQ41838064-770A679A-8B4D-4905-8C42-89CD52153CBAQ52655142-9091FD6A-62BD-40B6-9E4B-4F955BC10AFEQ53769826-BFA526DC-8DE0-4BEE-8003-347ADE8C876FQ58702607-4337CF8F-1F62-4AD6-B78C-670DCAB43E3A
P2860
Cyclopamine is a novel Hedgehog signaling inhibitor with significant anti-proliferative, anti-invasive and anti-estrogenic potency in human breast cancer cells.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
2013年论文
@zh
2013年论文
@zh-cn
name
Cyclopamine is a novel Hedgeho ...... in human breast cancer cells.
@ast
Cyclopamine is a novel Hedgeho ...... in human breast cancer cells.
@en
type
label
Cyclopamine is a novel Hedgeho ...... in human breast cancer cells.
@ast
Cyclopamine is a novel Hedgeho ...... in human breast cancer cells.
@en
prefLabel
Cyclopamine is a novel Hedgeho ...... in human breast cancer cells.
@ast
Cyclopamine is a novel Hedgeho ...... in human breast cancer cells.
@en
P2093
P2860
P356
P1433
P1476
Cyclopamine is a novel Hedgeho ...... in human breast cancer cells.
@en
P2093
Chao-Qian Zhao
Fu-Zheng Zhang
Sai-Jun Fan
Xu-Dong Hu
P2860
P304
P356
10.3892/OL.2013.1195
P577
2013-02-18T00:00:00Z